oxazolidin-2-one has been researched along with Influenza, Human in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fusco, DN; He, Y; Liu, X; Papanicolaou, GA; White, JR; Xiao, K | 1 |
Ballinger, MN; Bhan, U; Keshamouni, V; Kovach, MA; Podsiad, AB; Standiford, TJ | 1 |
2 other study(ies) available for oxazolidin-2-one and Influenza, Human
Article | Year |
---|---|
Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Coinfection; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Immunologic Factors; Influenza A virus; Influenza, Human; Interleukins; Linezolid; Lung; Mice; Mice, Inbred C57BL; Oxazolidinones; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Viral Load; Weight Loss | 2013 |
Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.
Topics: Acetamides; Animals; Humans; Immunomodulation; Influenza A Virus, H1N1 Subtype; Influenza, Human; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections | 2015 |